Skip to main content

Table 4 Clinical characteristics of patients carrying rare variants in LPL, LMF1, APOA5, APOE and GPIHBP1 genes

From: Frequency of rare mutations and common genetic variations in severe hypertriglyceridemia in the general population of Spain

Gene

Nucleotide change

Predicted aminoacid change

Age (years)

Sex

BMI (kg/m2)

TC, mg/dL

TG mg/dL

APOE Genotype

LPL

c.1018 + 1G > A

 

74

F

26.3

247

505

ε2/ε3

59

M

29.7

374

1736

ε3/ε4

LMF1

c.205C > T

p. (Leu69Leu)

65

M

24.2

257

654

ε3/ε4

c.1685C > G

p.(Pro562Arg)

28

M

26.85

286

932

ε2/ε3

APOE

c.460C > A

p.(Arg154Ser)

47

M

24.45

354

572

ε3/ε3

64

M

29.1

287

586

ε3/ε3

APOA5

c.289C > T

p.(Gln97*)

53

M

23.9

252

1215

ε2/ε3

c.518T > C

p.(Leu173Pro)

43

M

28.9

269

1410

ε3/ε4

GPIHBP1

c.226C > T

p.(Arg76Cys)

57

M

29.8

251

781

ε2/ε3

  1. BMI Body Mass Index, TC Total Cholesterol, TG Triglycerides, F female, M male